Immunocore Holdings plc - American Depositary Shares (NQ:IMCR)

30.98 -1.14 (-3.55%)

Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Immunocore Holdings plc - American Depositary Shares

< Previous 1 2 3 4 Next >

Immunocore Q2 Earnings Call Highlights ↗

August 06, 2026

Immunocore (NASDAQ:IMCR) reported continued growth for KIMMTRAK in the second quarter and first half of 2026, while advancing three late-stage melanoma trials and early-stage programs in oncology, HIV...

Via MarketBeat

Topics Earnings

Immunocore (NASDAQ:IMCR) Q2 Revenue Beats but EPS Misses, Shares Tumble ↗

August 06, 2026

Via Chartmill

Immunocore (IMCR) Q4 2025 Earnings Call Transcript ↗

February 25, 2026

Immunocore (IMCR) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Immunocore (IMCR) Q2 2025 Earnings Call Transcript ↗

November 27, 2025

Immunocore (IMCR) Q2 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Demystifying Immunocore Holdings: Insights From 9 Analyst Reviews ↗

June 02, 2025

Via Benzinga

What Analysts Are Saying About Immunocore Hldgs Stock ↗

February 27, 2025

Via Benzinga

Earnings Scheduled For February 26, 2025 ↗

February 26, 2025

Via Benzinga

Growth Picks: 3 Low-Cost Stocks That Could Double in Value ↗

October 27, 2025

Via MarketBeat

Immunocore (IMCR) Q2 Revenue Jumps 30% ↗

August 07, 2025

Via The Motley Fool

Topics Earnings Intellectual Property

Immunocore Holdings PLC (NASDAQ:IMCR) Beats Q2 2025 Revenue and EPS Estimates with Strong KIMMTRAK Sales Growth ↗

August 07, 2025

Immunocore (IMCR) beat Q2 2025 estimates with $98M revenue (+30% YoY) and a narrower EPS loss. KIMMTRAK sales surged 32%, while pipeline progress and strong cash position ($882.8M) boosted investor...

Via Chartmill

Analyst Expectations For Immunocore Holdings's Future ↗

April 07, 2025

Via Benzinga

Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday ↗

March 20, 2025

Via Benzinga

Analyst Expectations For Immunocore Hldgs's Future ↗

January 27, 2025

Via Benzinga

Navigating 8 Analyst Ratings For Immunocore Hldgs ↗

November 11, 2024

Via Benzinga

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday? ↗

December 13, 2024

Morgan Stanley downgrades Amicus Therapeutics, Immunocore, and Immuneering, citing pricing challenges, pipeline updates, and cautious growth outlooks.

Via Benzinga

3 Fast-Growing Stocks Analysts See Doubling in Price

November 11, 2024

Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.

Via MarketBeat

A Closer Look at 9 Analyst Recommendations For Immunocore Hldgs ↗

October 24, 2024

Via Benzinga

Analyst Ratings For Immunocore Hldgs ↗

October 07, 2024

Via Benzinga

GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

September 17, 2024

Via Benzinga

Analyst Expectations For Immunocore Hldgs's Future ↗

September 17, 2024

Via Benzinga

The Latest Analyst Ratings For Immunocore Hldgs ↗

August 28, 2024

Via Benzinga

Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings) ↗

August 09, 2024

Via Benzinga

3 Small-Cap Stocks with Significant Growth Potential ↗

August 06, 2024

As sector rotation continues, it could be time for investors to consider these small-cap growth stocks that institutions love.

Via InvestorPlace

Peeling Back The Layers: Exploring Immunocore Hldgs Through Analyst Insights ↗

July 10, 2024

Via Benzinga

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 03, 2024

Via Benzinga

Analyst Expectations For Immunocore Hldgs's Future ↗

May 24, 2024

Via Benzinga

Where Immunocore Hldgs Stands With Analysts ↗

April 29, 2024

Via Benzinga

Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 24, 2024

Via Benzinga

IMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024 ↗

May 08, 2024

IMCR stock results show that Immunocore Hldgs missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.